These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 24034049)

  • 1. A newly identified mutation in the complement factor I gene not associated with early post-transplant recurrence of atypical hemolytic-uremic syndrome: a case report.
    Ranghino A; Tognarelli G; Basso E; Messina M; Manzione AM; Daidola G; Segoloni GP
    Transplant Proc; 2013 Sep; 45(7):2785-7. PubMed ID: 24034049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful long-term outcome after renal transplantation in a patient with atypical haemolytic uremic syndrome with combined membrane cofactor protein CD46 and complement factor I mutations.
    Pabst WL; Neuhaus TJ; Nef S; Bresin E; Zingg-Schenk A; Spartà G
    Pediatr Nephrol; 2013 Jul; 28(7):1141-4. PubMed ID: 23519521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recurrent atypical hemolytic uremic syndrome associated with factor I mutation in a living related renal transplant recipient.
    Chan MR; Thomas CP; Torrealba JR; Djamali A; Fernandez LA; Nishimura CJ; Smith RJ; Samaniego MD
    Am J Kidney Dis; 2009 Feb; 53(2):321-6. PubMed ID: 18805611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful renal transplantation in a patient with atypical hemolytic uremic syndrome carrying mutations in both factor I and MCP.
    Cruzado JM; de Córdoba SR; Melilli E; Bestard O; Rama I; Sánchez-Corral P; López-Trascasa M; Navarro I; Torras J; Gomà M; Grinyó JM
    Am J Transplant; 2009 Jun; 9(6):1477-83. PubMed ID: 19459807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implications of the initial mutations in membrane cofactor protein (MCP; CD46) leading to atypical hemolytic uremic syndrome.
    Richards A; Kathryn Liszewski M; Kavanagh D; Fang CJ; Moulton E; Fremeaux-Bacchi V; Remuzzi G; Noris M; Goodship TH; Atkinson JP
    Mol Immunol; 2007 Jan; 44(1-3):111-22. PubMed ID: 16882452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Managing and preventing atypical hemolytic uremic syndrome recurrence after kidney transplantation.
    Noris M; Remuzzi G
    Curr Opin Nephrol Hypertens; 2013 Nov; 22(6):704-12. PubMed ID: 24076560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Living Donor Kidney Transplantation in Atypical Hemolytic Uremic Syndrome: A Case Series.
    Duineveld C; Verhave JC; Berger SP; van de Kar NCAJ; Wetzels JFM
    Am J Kidney Dis; 2017 Dec; 70(6):770-777. PubMed ID: 28821363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Post-transplant recurrence of atypical hemolytic uremic syndrome in a patient with thrombomodulin mutation.
    Sinibaldi S; Guzzo I; Piras R; Bresin E; Emma F; Dello Strologo L
    Pediatr Transplant; 2013 Dec; 17(8):E177-81. PubMed ID: 24118826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A mutation in factor I that is associated with atypical hemolytic uremic syndrome does not affect the function of factor I in complement regulation.
    Nilsson SC; Karpman D; Vaziri-Sani F; Kristoffersson AC; Salomon R; Provot F; Fremeaux-Bacchi V; Trouw LA; Blom AM
    Mol Immunol; 2007 Mar; 44(8):1835-44. PubMed ID: 17084897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two patients with history of STEC-HUS, posttransplant recurrence and complement gene mutations.
    Alberti M; Valoti E; Piras R; Bresin E; Galbusera M; Tripodo C; Thaiss F; Remuzzi G; Noris M
    Am J Transplant; 2013 Aug; 13(8):2201-6. PubMed ID: 23731345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atypical hemolytic uremic syndrome: update on the complement system and what is new.
    Hirt-Minkowski P; Dickenmann M; Schifferli JA
    Nephron Clin Pract; 2010; 114(4):c219-35. PubMed ID: 20090363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haemolytic uraemic syndrome caused by factor H mutation: is single kidney transplantation under intensive plasmatherapy an option?
    Hirt-Minkowski P; Schaub S; Mayr M; Schifferli JA; Dickenmann M; Frémeaux-Bacchi V; Steiger J
    Nephrol Dial Transplant; 2009 Nov; 24(11):3548-51. PubMed ID: 19633317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atypical hemolytic uremic syndrome recurrence after kidney transplantation.
    Matar D; Naqvi F; Racusen LC; Carter-Monroe N; Montgomery RA; Alachkar N
    Transplantation; 2014 Dec; 98(11):1205-12. PubMed ID: 24933457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transplantation in atypical hemolytic uremic syndrome.
    Kavanagh D; Richards A; Goodship T; Jalanko H
    Semin Thromb Hemost; 2010 Sep; 36(6):653-9. PubMed ID: 20865642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insights into hemolytic uremic syndrome: segregation of three independent predisposition factors in a large, multiple affected pedigree.
    Esparza-Gordillo J; Jorge EG; Garrido CA; Carreras L; López-Trascasa M; Sánchez-Corral P; de Córdoba SR
    Mol Immunol; 2006 Apr; 43(11):1769-75. PubMed ID: 16386793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A favorable 3-year outcome of kidney transplantation in atypical hemolytic uremic syndrome associated with a factor H mutation: case report.
    Albertazzi V; Bonucchi D; De Amicis S; Americo C; Ghiandai G; Cappelli G
    Transplant Proc; 2010 May; 42(4):1352-4. PubMed ID: 20534299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic and functional analyses of membrane cofactor protein (CD46) mutations in atypical hemolytic uremic syndrome.
    Fremeaux-Bacchi V; Moulton EA; Kavanagh D; Dragon-Durey MA; Blouin J; Caudy A; Arzouk N; Cleper R; Francois M; Guest G; Pourrat J; Seligman R; Fridman WH; Loirat C; Atkinson JP
    J Am Soc Nephrol; 2006 Jul; 17(7):2017-25. PubMed ID: 16762990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutations in components of complement influence the outcome of Factor I-associated atypical hemolytic uremic syndrome.
    Bienaime F; Dragon-Durey MA; Regnier CH; Nilsson SC; Kwan WH; Blouin J; Jablonski M; Renault N; Rameix-Welti MA; Loirat C; Sautés-Fridman C; Villoutreix BO; Blom AM; Fremeaux-Bacchi V
    Kidney Int; 2010 Feb; 77(4):339-49. PubMed ID: 20016463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The interactive Factor H-atypical hemolytic uremic syndrome mutation database and website: update and integration of membrane cofactor protein and Factor I mutations with structural models.
    Saunders RE; Abarrategui-Garrido C; Frémeaux-Bacchi V; Goicoechea de Jorge E; Goodship TH; López Trascasa M; Noris M; Ponce Castro IM; Remuzzi G; Rodríguez de Córdoba S; Sánchez-Corral P; Skerka C; Zipfel PF; Perkins SJ
    Hum Mutat; 2007 Mar; 28(3):222-34. PubMed ID: 17089378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Posttransplant recurrence of atypical hemolytic uremic syndrome.
    Valoti E; Alberti M; Noris M
    J Nephrol; 2012; 25(6):911-7. PubMed ID: 22760880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.